CDKN2A and head and neck squamous cell carcinoma: This study aims to comprehensively investigate the role of p16 in both HPV-positive and HPV-negative HNSCC, focusing on its regulatory mechanisms, diagnostic and prognostic implications, and potential as a therapeutic target.